Hyperkalemia in CKD and Heart Failure: Strategies for Risk Reduction and Management
This content is a production of Drug Topics; this Pharmacist Video is supported by funding from AstraZeneca. AstraZeneca was not involved in the creation of the content for this Video.
An expert discusses the causes and clinical impact of hyperkalemia in chronic kidney disease and heart failure, evaluates current monitoring and treatment approaches across care settings, and highlights pharmacist-led interventions that integrate hyperkalemia management into comprehensive chronic disease care pathways.
EP. 1: Risk Factors, Epidemiology, and Patient Burden Associated With Hyperkalemia
July 30th 2025An expert discusses the increased prevalence and complexity of hyperkalemia in patients with chronic kidney disease and heart failure, emphasizing how both disease-related factors and common medications contribute to elevated potassium levels, while also highlighting the clinical trade-offs, patient lifestyle burdens, and the need for holistic, patient-centered management approaches.
